These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
125 related items for PubMed ID: 6642878
1. Plasma levels of tricyclic antidepressants in panic disorder. Sweeney DR, Gold MS, Pottash AL, Martin D. Int J Psychiatry Med; ; 13(2):93-6. PubMed ID: 6642878 [Abstract] [Full Text] [Related]
2. The relationship of plasma imipramine and N-desmethylimipramine to improvement in agoraphobia. Mavissakalian M, Perel JM, Michelson L. J Clin Psychopharmacol; 1984 Feb; 4(1):36-40. PubMed ID: 6693582 [Abstract] [Full Text] [Related]
3. Follow-up study of patients with panic disorder and agoraphobia with panic attacks treated with tricyclic antidepressants. Noyes R, Garvey MJ, Cook BL. J Affect Disord; 1989 Feb; 16(2-3):249-57. PubMed ID: 2522124 [Abstract] [Full Text] [Related]
4. Preliminary results of an open, fixed-dose study of desipramine in panic disorder. Lydiard RB. Psychopharmacol Bull; 1987 Feb; 23(1):139-40. PubMed ID: 3602310 [No Abstract] [Full Text] [Related]
5. Fluoxetine in panic disorder patients with imipramine-associated weight gain. Brady K, Zarzar M, Lydiard RB. J Clin Psychopharmacol; 1989 Feb; 9(1):66-7. PubMed ID: 2785123 [No Abstract] [Full Text] [Related]
6. Imipramine dose-response relationship in panic disorder with agoraphobia. Preliminary findings. Mavissakalian MR, Perel JM. Arch Gen Psychiatry; 1989 Feb; 46(2):127-31. PubMed ID: 2643933 [Abstract] [Full Text] [Related]
7. A comparison of alprazolam and imipramine in the treatment of agoraphobia and panic disorder. Rizley R, Kahn RJ, McNair DM, Frankenthaler LM. Psychopharmacol Bull; 1986 Feb; 22(1):167-72. PubMed ID: 2873609 [No Abstract] [Full Text] [Related]
8. The relationship of plasma imipramine and N-desmethylimipramine to improvement in agoraphobia. Mavissakalian M, Perel J, Michelson L. Psychopharmacol Bull; 1984 Feb; 20(1):123-5. PubMed ID: 6718637 [No Abstract] [Full Text] [Related]
11. Clinical response to clonidine and imipramine, and platelet alpha 2-adrenoreceptors in a case of agoraphobia with panic attacks. Zelnik TC, Garcia-Sevilla JA, Cameron OG, Smith CB. Biol Psychiatry; 1982 Jun; 17(6):761-6. PubMed ID: 6285996 [No Abstract] [Full Text] [Related]
14. Three cases of panic disorder with agoraphobia in children. Ballenger JC, Carek DJ, Steele JJ, Cornish-McTighe D. Am J Psychiatry; 1989 Jul; 146(7):922-4. PubMed ID: 2742019 [Abstract] [Full Text] [Related]
15. Differential treatment of phobias: use of imipramine for panic attacks. Zitrin CM. J Behav Ther Exp Psychiatry; 1983 Mar; 14(1):11-8. PubMed ID: 6134756 [Abstract] [Full Text] [Related]
16. Differential effects of imipramine and behavior therapy on panic disorder with agoraphobia. Mavissakalian M. Psychopharmacol Bull; 1989 Mar; 25(1):27-9. PubMed ID: 2672069 [No Abstract] [Full Text] [Related]
17. Pharmacokinetics and clinical effects of alprazolam following single and multiple oral doses in patients with panic disorder. Ciraulo DA, Barnhill JG, Boxenbaum HG, Greenblatt DJ, Smith RB. J Clin Pharmacol; 1986 Apr; 26(4):292-8. PubMed ID: 2871050 [Abstract] [Full Text] [Related]
18. A naturalistic study of imipramine in panic disorder and agoraphobia. Aronson TA. Am J Psychiatry; 1987 Aug; 144(8):1014-9. PubMed ID: 3300374 [Abstract] [Full Text] [Related]
19. Tricyclic antidepressants and monoamine oxidase inhibitors in the treatment of agoraphobia. Pohl R, Berchou R, Rainey JM. J Clin Psychopharmacol; 1982 Dec; 2(6):399-407. PubMed ID: 7174863 [Abstract] [Full Text] [Related]